Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of PLCD1 mRNA | affects expression | 17562736
|
D000535 |
Aluminum |
Aluminum results in increased expression of PLCD1 protein | increases expression | 10814511
|
C432165 |
anthra(1,9-cd)pyrazol-6(2H)-one |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Norepinephrine results in increased expression of PLCD1 mRNA] | decreases reaction|increases expression | 19225867
|
D019324 |
beta-Naphthoflavone |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLCD1 mRNA | affects cotreatment|increases expression | 18164116
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PLCD1 mRNA | increases expression | 15003993
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of PLCD1 mRNA | affects expression | 17484886
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PLCD1 mRNA | affects cotreatment|increases expression | 18164116
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of PLCD1 mRNA | decreases expression | 18035473
|
D007657 |
Ketone Bodies |
Ketone Bodies results in decreased expression of PLCD1 mRNA | decreases expression | 15469884
|
D009638 |
Norepinephrine |
anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Norepinephrine results in increased expression of PLCD1 mRNA] | decreases reaction|increases expression | 19225867
|
D009638 |
Norepinephrine |
Norepinephrine results in increased expression of and results in increased activity of PLCD1 protein | increases activity|increases expression | 19225867
|
D009638 |
Norepinephrine |
Norepinephrine results in increased expression of PLCD1 mRNA | increases expression | 19225867
|
D009638 |
Norepinephrine |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCD1 protein] | decreases reaction|increases activity|increases expression | 19225867
|
D009638 |
Norepinephrine |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCD1 mRNA] | decreases reaction|increases expression | 19225867
|
D010126 |
Ozone |
Ozone results in decreased expression of PLCD1 mRNA | decreases expression | 16330353
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of and results in increased activity of PLCD1 protein] | decreases reaction|increases activity|increases expression | 19225867
|
D011224 |
Prazosin |
Prazosin inhibits the reaction [Norepinephrine results in increased expression of PLCD1 mRNA] | decreases reaction|increases expression | 19225867
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of PLCD1 mRNA | increases expression | 19101580
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
3.60 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.01 | 19490988 |
MESH:D000236 |
Adenoma |
|
beta-Naphthoflavone |
7.03 | 19389873 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
7.03 | 10737359 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
4.02 | 17620307 18056438 19061943 19052882 17162532 16434500 |
MESH:D000544 |
Alzheimer Disease |
|
Aluminum |
4.86 | 17662457 10721010 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
4.86 | 15513908 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.37 | 17688650 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.98 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.64 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.57 | 15570426 |
MESH:D001249 |
Asthma |
|
Ozone |
2.66 | 16373670 17854713 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
2.30 | 18445737 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
2.30 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.30 | 17507914 17688650 19232924 17157402 18316065 18775368 18558336 16609825 18396377 18940202 20603192 18177632 19460635 15238991 18985861 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.11 | 20046352 17594078 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.45 | 8888407 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
2.22 | 17474063 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.74 | 18417511 18315731 15516495 14754758 16777450 17626835 19059883 |
MESH:D002100 |
Cachexia |
|
Ozone |
4.86 | 16183385 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.88 | 16227642 16097048 15673190 16192424 15721981 16011737 10355542 18705752 15700767 3786805 16050911 16124888 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
6.71 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
6.71 | 19418558 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
6.71 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
6.71 | 19335982 17173139 19383236 20524982 20084675 19052882 18971187 19822196 16540662 17138121 18691550 10672840 18978308 3084413 20432363 18210153 16807293 19919837 18056438 11831363 19107877 16779866 20514400 18506893 16698587 19171122 18788625 19701751 18665156 16288022 20512989 17978847 17162532 17055752 16681979 18393292 16328049 21159647 18785209 19208518 20935162 17761372 16878318 20214788 19394651 16569478 19519916 19539802 20007298 16935385 17428255 20727157 18494052 3581430 16830150 20101231 19418558 16502159 10737359 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
4.41 | 11179087 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
5.65 | 8216760 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.63 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
2.91 | 2727394 21159647 17174075 7505956 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.73 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
3.76 | 19052882 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 16575769 8888407 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
2.21 | 20387270 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
12.30 | 10915739 16393943 16177239 10774834 17906064 12594235 19085960 19923254 18071297 12958197 15968718 18713872 17522070 11834606 16081117 19164858 11743745 14550746 19416960 12540782 11421492 10663392 16781746 16227642 11461765 2444490 19739265 17562736 11287661 15619225 16109766 19420014 11529661 19370779 14725611 16485898 11739529 14986274 12705907 12392966 12153990 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
12.30 | 9327722 3786805 2869522 15027814 3732212 10915739 16227642 7120509 7440962 10092053 4309450 21278145 15968718 6623471 16177239 7179309 17522070 6884620 19085960 11566570 19336974 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
12.30 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Prazosin |
12.30 | 18071297 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
12.30 | 19641884 1733752 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.23 | 19426721 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.14 | 1851702 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.26 | 17275665 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.05 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
7.31 | 821787 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
7.31 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.66 | 6254150 6426943 7562514 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.40 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.18 | 3659116 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.25 | 16302075 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.65 | 12795759 12631006 16045604 16239168 61145 15959796 19224547 17595544 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
13.65 | 21071580 20387270 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
13.65 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.02 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.23 | 8888407 18558336 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
3.56 | 18705752 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.81 | 16983495 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.69 | 19900420 19110552 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.98 | 17688650 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
8.45 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Prazosin |
8.45 | 12727271 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.65 | 16899240 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
4.19 | 15338365 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
5.08 | 6740701 |
MESH:D007249 |
Inflammation |
|
Aluminum |
8.83 | 16052892 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.83 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.83 | 17296493 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.24 | 15629191 12587719 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
anthra(1,9-cd)pyrazol-6(2H)-one |
5.49 | 16972261 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.16 | 16294345 17596541 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.75 | 11408273 17334410 16943688 16221502 17174718 11903743 17157831 21278145 16239168 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
6.75 | 20032147 18407596 18522880 18665156 19638242 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
1.75 | 10355542 16248980 16192424 17714472 18705752 14716496 15876570 14716833 18166357 15052691 12741479 18376398 12586293 18472332 18156304 17481882 18279442 17922224 12632512 18251166 17766677 18210741 17557913 12445418 18205269 17805973 12546737 18420326 15123356 15730626 16097048 15338365 18395914 18263696 12898905 16015684 18412020 18054572 18187930 18277467 11481614 18395095 17721639 16033810 17640975 17869086 18339082 17761835 17944888 17976157 18429990 15959796 14724832 18006644 13678700 12632514 16116963 14620537 17900296 12609069 18418968 17708605 15893842 15925388 17525996 14748882 17565644 18472094 12445421 17698563 18481824 15931870 12958196 12389079 15650968 16136751 15818738 16638106 18317297 12649538 16027843 14512876 12667390 15370692 15057751 12666154 20821823 17823541 15996030 16011737 17631135 15673190 15362042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
6.59 | 16610002 19460945 11587558 19784758 16611625 19014921 12587719 12969438 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
6.59 | 16246199 16964402 15720792 15830285 17285989 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
6.59 | 17034775 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.27 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
9.67 | 16871587 17185352 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
9.67 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
beta-Naphthoflavone |
7.69 | 21295105 19389873 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
7.69 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
7.69 | 19690152 19294768 18644402 2862719 20137499 21047994 12112319 15885732 19073162 19996281 12771043 20118626 18754104 21167192 19499222 16942905 20101389 19642983 18977376 20492335 18648771 20434301 19638242 19551842 15175105 2422723 20452335 19850985 19254457 18978307 19426721 20501860 21278145 19833225 19812893 20405173 19427195 19090486 21071580 20583210 19255062 10737359 19256749 9163691 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
beta-Naphthoflavone |
10.22 | 18164116 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
10.22 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.22 | 16842330 18775883 17174075 18164116 17942915 18079962 19539802 18253720 3124819 18544905 9362446 19519916 18093689 19004024 18282651 17854601 16267830 19126423 21159647 18308698 19009564 2563599 |
MESH:D008171 |
Lung Diseases |
|
Aluminum |
8.24 | 16052892 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
8.24 | 8266340 19066396 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.40 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.95 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.59 | 20970405 20512841 6695378 21163286 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
2.59 | 7614698 8597069 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.67 | 19513568 |
MESH:D008679 |
Metaplasia |
|
Ozone |
5.24 | 10496685 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.25 | 18765137 18803445 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Aluminum |
6.51 | 17086897 |
MESH:D020529 |
Multiple Sclerosis, Relapsing-Remitting |
|
Aluminum |
6.51 | 17086897 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.11 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.20 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
4.91 | 15642760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.59 | 3581430 9029167 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.18 | 8888407 16359493 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.41 | 18514411 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
8.41 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.25 | 20387270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.46 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.45 | 16540662 |
MESH:D010538 |
Peritonitis |
|
Ozone |
4.23 | 16369182 |
MESH:D011014 |
Pneumonia |
|
Ozone |
4.51 | 18007984 18381685 18929643 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.62 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
3.95 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.67 | 12752131 11422049 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.26 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.08 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.79 | 1511512 15475178 3137016 11738929 14763951 16876388 11044598 17978042 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
2.72 | 8532709 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.84 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.67 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
5.53 | 3261545 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.04 | 7505956 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.37 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.64 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.75 | 8888407 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.06 | 10982225 |